Mast cell activation in the skin of Plasmodium falciparum malaria patients by Panop Wilainam et al.
Mast cell activation in the skin of Plasmodium
falciparum malaria patients
Wilainam et al.
Wilainam et al. Malaria Journal  (2015) 14:67 
DOI 10.1186/s12936-015-0568-8
Wilainam et al. Malaria Journal  (2015) 14:67 
DOI 10.1186/s12936-015-0568-8RESEARCH Open AccessMast cell activation in the skin of Plasmodium
falciparum malaria patients
Panop Wilainam1, Rungrat Nintasen2 and Parnpen Viriyavejakul3*Abstract
Background: Mast cells (MCs) play an important role in the immune response and inflammatory processes.
Generally, MCs can be stimulated to degranulate and release histamine upon binding to immunoglobulin E (IgE). In
malaria, MCs have been linked to immunoglobulin (Ig) E-anti-malarial antibodies. This study investigated the
response of MCs in the skin of patients with Plasmodium falciparum malaria.
Methods: Skin tissue samples were examined from ten uncomplicated and 20 complicated P. falciparum malaria cases.
Normal skin tissues from 29 cases served as controls. Pre- and post-treatment tissues were included. Histopathological
changes of the skin were evaluated using haematoxylin and eosin stain. MCs were investigated using toluidine blue
staining. The percentage of MC degranulation was compared among groups and correlated with clinical data.
Results: MC degranulation was significantly higher in the complicated P. falciparum (43.72% ± 1.44) group than the
uncomplicated P. falciparum (31.35% ± 3.29) (p <0.05) and control groups (18.38% ± 1.75), (p <0.0001). MC degranulation
correlated significantly with the degree of parasitaemia (rs = 0.66, p <0.0001). Associated pathological features, including
extravasation of red blood cells, perivascular oedema and leukocyte infiltration were significantly increased in the malaria
groups compared with the control group (all p <0.001).
Conclusions: MCs in the skin dermis are activated during malaria infection, and the degree of MC degranulation
correlates with parasitaemia and disease severity.
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Malaria is the most serious and widespread parasitic dis-
ease in humans, occurring widely throughout the tropical
areas of the world. In 2012, 207 million cases of malaria
were reported, with 627,000 deaths [1]. The process of
malaria pathogenesis is very complex, mainly involving
the effects of cytoadhesion and sequestration of parasit-
ized red blood cells (PRBCs) in the vital organs [2] and the
induction of soluble cytokines [3,4]. The major complica-
tions of severe Plasmodium falciparum malaria include
cerebral malaria, pulmonary oedema, acute kidney injury,
severe anaemia, bleeding, acidosis and hypoglycaemia [5].
These complications can develop rapidly and progress to
death within hours or days [6].
Mast cells (MCs) are pivotal effector cells in allergic dis-
eases, and play a role in the body’s inflammatory response* Correspondence: parnpen.vir@mahidol.ac.th
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unless otherwise stated.and immunity. These immune cells are abundant in tis-
sues exposed to the external environment, including the
skin [7,8]. MCs can be activated by various stimuli includ-
ing cytokines, chemokines and neuropeptides. The bio-
logical effects of MCs depend on the release of preformed
and de novo-synthesized mediators such as histamine, pro-
teases, leukotrienes, and various cytokines [9]. MCs are best
known for immunoglobulin (Ig) E-mediated immediate-
type hypersensitivity reactions [10]. In P. falciparum infec-
tion, the significant elevation of the blood concentrations of
IgE, IgE-anti-malarial antibodies and histamine have been
associated with disease severity in human [11] and animal
models [12]. Morphologically, MCs have not been evalu-
ated in malaria. This study aimed to investigate the re-
sponse of MCs in the skin of patients with P. falciparum
malaria.al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Patients and normal cases
Skin biopsied specimens from P. falciparum malaria pa-
tients were classified into two groups, uncomplicated (ten
cases) and complicated (20 cases) P. falciparum malaria
cases, according to the available history in the clinical
chart, based on WHO criteria [5]. All P. falciparum mal-
aria patients enrolled had no history of underlying disease.
Normal skin tissues served as control cases (29 cases). All
tissues were retrieved from paraffin-embedded specimens
collected at the Department of Tropical Pathology, Faculty
of Tropical Medicine, Mahidol University. The use of left-
over specimens was approved by the Ethics Committee of
the Faculty of Tropical Medicine, Mahidol University,
Bangkok, Thailand (MUTM 2013-044-01).
Histopathological study
The collected skin tissues in paraffin blocks were re-
embedded, sectioned at 4 μm thickness and stained with
routine haematoxylin and eosin (H&E) stain for histo-
pathological examination. MCs were evaluated using
toluidine blue stain modified from Mills et al. [13].
Briefly, after deparaffinization and hydration, the sec-
tions were immersed in 0.1% toluidine blue working so-
lution for 5–10 min and washed in distilled water, with
three changes. The tissues were then dehydrated quickly
through 90%, and two changes of absolute ethanol. Sec-
tions were then cleared in xylene, and mounted with
mounting medium.Table 1 Clinical data of Plasmodium falciparum malaria
Uncomplicated*
P. falciparum
malaria (n = 5)
Complicated
P. falciparum
malaria (n = 20)
Age 28 29
Gender (male: female) 5:0 12:8
Days of fever (p = 0.41) 3.6 ± 0.98 4.45 ± 0.44
Admission parasite
count/μL (p = 0.51)
52,638 ± 12,990 181,315 ± 55,314
WBC (×109/L) (p = 0.041) 5.82 ± 1.24 9.61 ± 0.79
Hb (g/dL) (p = 0.17) 12.70 ± 1.35 11.10 ± 0.56Evaluation of MCs
MCs (both intact and degranulated forms) were quantified
in two areas, the upper dermis (papillary layer) and the
lower dermis (reticular and subcutaneous fatty layers).
MCs were counted in 15 fields each, at the areas adjacent
to the blood vessels, and in the connective tissues, under
high-power magnification (400×). For specimens with a
small counting area, all MCs were evaluated before the
percentage of degranulated MCs was calculated. Paren-
chymatous changes, including extravasation of RBCs, peri-
vascular oedema, and the presence of leukocytes, were
quantified and presented as percentages.Platelets (×109/L) (p = 0.20) 50.60 ± 7.98 70.85 ± 28.69
BUN (ml/dL) (p = 0.51) 24.84 ± 4.86 34.96 ± 5.70
Creatinine (ml/dL) (p = 0.73) 1.06 ± 0.11 2.21 ± 0.70
TB (mg/dL) (p = 0.01) 1.91 ± 0.34 5.88 ± 1.14
DB (mg/dL) (p = 0.0073) 0.56 ± 0.23 3.34 ± 0.80
AST (IU/L) (p = 0.0012) 25.40 ± 3.56 112.0 ± 21.50
ALT (IU/L) (p = 0.0039) 21.80 ± 5.23 90.85 ± 15.19
*Clinical data available for 5 uncomplicated P. falciparum malaria patients.
WBC-white blood cell count, Hb-haemoglobin, BUN-blood urea nitrogen,
TB-total bilirubin, DB-direct bilirubin, AST-aspartate aminotransferase,
ALT-alanine aminotransferase. Data expressed as mean ± SEM.Statistical analysis
Differences among the three groups were analysed using
the Kruskal-Wallis test, and expressed as geometric
means ± standard error of the mean (SEM). The Mann–
Whitney U test was used to compare between malaria
groups, and between pre- and post- treatment data. The
Statistical Package for the Social Sciences (SPSS) version
11.0 software (SPSS Chicago, IL, USA) was used, and a
value of p <0.05 was deemed statistically significant.Results
Clinical data of malaria patients
Uncomplicated P. falciparum patients usually presented
with mild symptoms including fever, headache, myalgia,
chills, and nausea. Seventy five percent of complicated
malaria cases were associated with cerebral malaria, 30%
with acute kidney injury, 45% with hyperparasitaemia,
35% with schizontaemia and 35% with severe anaemia.
The clinical details of the malaria patients are shown in
Table 1. Variables showing significant differences between
the two groups included the number of white blood cells
(WBCs), the levels of total and direct bilirubin, aspartate
and alanine aminotransferases (all p <0.05). Artemisinin
derivatives were used for the treatment of both uncompli-
cated and complicated P. falciparum malaria patients.
Evaluation of degranulated mast cells
An intact MC is defined as a MC with granulated struc-
tures confined within the cell membrane, while a MC is
considered degranulated when granules are found outside
the cell (Figure 1). PRBCs were occasionally seen in the
dermal blood vessels (Figure 2). MC degranulation was
significantly higher in the complicated P. falciparum
(43.72% ± 1.44) group than the uncomplicated P. falcip-
arum (31.35% ± 3.29, p <0.05) or control group (18.38% ±
1.75, p <0.0001) (Figure 3). In addition, MC degranulation
in the uncomplicated P. falciparum malaria cases was sig-
nificantly higher than the control group (p <0.0001). No
difference was found between pre- and post-treatment in
both malaria groups. The mean number of MCs per high
Figure 1 Intact (arrow) and degranulated (arrow head) MCs
around a small blood vessel in the dermis. BV-blood vessel,
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Figure 3 Percentage MC degranulation in Plasmodium
falciparum malaria. MC degranulation in malaria patients was
significantly increased compared with controls. *p <0.05- significant
difference as compared to control group, **p <0.05- significant
difference between uncomplicated and complicated malaria groups,
ns- non-significant.
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1.83 ± 0.24 in the uncomplicated P. falciparum group, and
2.69 ± 0.22 in the complicated P. falciparum group. At
seven days post-treatment, total percentage MC degranu-
lation remained elevated in both malaria groups, similar
to pre-treatment (p >0.05). MC degranulation percent-
age correlated significantly with parasitaemia (rs = 0.66,
p <0.0001) (Figure 4).
Histopathologic changes in the skin of malaria patients
The skin epidermis of all groups appeared similar and
unremarkable. Within the dermis, RBC extravasation,
perivascular oedema, and leukocytic infiltration were sig-
nificant features of complicated P. falciparum malaria
(Figure 5). Extravasation of RBCs or diapedesis is definedFigure 2 Parasitized red blood cells (arrows) within the dermal
blood vessel. Haematoxylin and eosin stain, 400× magnification,
Bar = 10 μm.as the presence of RBCs intermixed with PRBCs and leu-
kocytes within the skin parenchyma [14] (Figure 5A). Ex-
travasated RBCs were more commonly seen in the
papillary layer, and significantly more numerous in P. fal-
ciparum malaria than control cases (all p <0.05). In com-
plicated P. falciparum malaria, RBC extravasation was
significantly increased (by 23.76%) in post-treatment, com-
pared with pre-treatment (p <0.0001). However, there was
no change in RBC extravasation between pre- and post-
treatment in the uncomplicated malaria group (Figure 6A).
























Figure 4 Correlation between percentage MC degranulation
and parasitaemia (/μl).
Figure 5 Histopathologic findings of the skin in Plasmodium
falciparum malaria patients. Extravasation of RBCs in the dermis is
shown in (A). (B) illustrates perivascular oedema, and (C) shows
leukocytic infiltration around blood vessels. Haematoxylin and eosin





















































































Figure 6 Comparative histopathologic changes in the skin of
Plasmodium falciparum malaria patients. All histopathologic changes
were significantly increased in malaria patients compared with controls.
(A) Percentage extravasation of RBCs, (B) Perivascular oedema, and
(C) Leukocyte infiltration, *p <0.05- significant difference as compared to
control group, **p <0.05- significant difference between uncomplicated
and complicated malaria groups, or between pre- and post-treatment
groups, ns- non-significant.
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around blood vessels (Figure 5B). This is commonly found
around small blood vessels deep in the dermis, in the re-
ticular and subcutaneous fatty layer more than in the pap-
illary layer. The perivascular oedema of uncomplicated
and complicated P. falciparum malaria was significantly
higher than control group (all p <0.001). In the post-
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decreased by 36.05% in uncomplicated P. falciparum mal-
aria, compared with pre-treatment (p <0.0001); however,
this was not observed in complicated P. falciparum mal-
aria (Figure 6B). Commonly observed leukocyte infiltra-
tions included mononuclear cells, such as lymphocytes
and monocytes; while neutrophils, eosinophils, basophils,
and plasma cells were rare. Leukocytes appeared to infil-
trate around the blood vessels and were located mostly in
the reticular layer (Figure 5C). Leukocytic infiltration in
malaria groups was significantly higher in both uncompli-
cated and complicated P. falciparum malaria compared
with the controls (all p <0.0001) (Figure 6C). Leukocytic
infiltration decreased by 28.61% in complicated P. falcip-
arum post-treatment (p <0.0001), but there was no change
in uncomplicated P. falciparum malaria.
Discussion
MCs have been implicated in the inflammatory response
and allergic process by releasing various cytokines, asso-
ciated with IgE-mediated immediate-type hypersensitiv-
ity reactions [9,15]. This study is the first to investigate
the response of MCs in the skin tissues of P. falciparum
malaria-infected patients. MCs were localized mostly in
the papillary layer, which correlated with blood vessel
density and contributed to an immediate defense against
stimuli [16]. MC degranulation is a characteristic pattern
of immunological and morphological changes after acti-
vation [17]. Generally, an increase in degranulated MCs
can result in MC activation syndrome (MCAS). The syn-
drome includes a range of manifestations, involving the
skin, gastrointestinal, cardiovascular, respiratory, and
neurological system [18]. In malaria infection, studies
have shown that IgE level is associated with malaria se-
verity [19,20]. In addition, malaria antigens have been re-
ported to activate macrophages and monocytes to produce
various cytokines, such as tumour necrosis factor (TNF)-
alpha [20,21] and interleukin-1 beta [22]. These cytokines,
which are classified as MC secretagogues, may activate
MCs through FcεRI receptors. The increased level of these
cytokines is related to malaria severity, and is hypothesized
to affect the response of MCs. MCs provide a potential
source of TNF during the early phase of infection. In an
animal malaria model, a study showed an association be-
tween MCs and the elevation of serum TNF, which could
contribute to malaria protection [23]. Increases in the
number of MCs, and MC degranulation, have been docu-
mented in diseases such as renal amyloidosis [24], intersti-
tial lung fibrosis [25], gastrointestinal disease [26] and
myocardial infarction [27]. The changes correlated with
pathological alterations, and are relevant to MC mediators.
Artemisinin derivatives were the drugs of choice used
to treat all malaria cases. A previous report has docu-
mented that artemisinin can decrease MC degranulationby blocking IgE-induced MC degranulation in an ana-
phylactic animal model [16]. However, in this study, the
number of MC degranulations remained elevated at
seven days post-treatment. Thus, artemisinin may not
prevent MC degranulation in malaria in vivo. Quinine
and tetracycline have also been reported to cause MC
degranulation [28]. Mefloquine was recently reported to
function as an anti-mast cell agent, inducing apoptosis
through a granule-mediated pathway [29]. The effects of
anti-malarial drugs on mast cell degranulation need to
be further investigated to determine the physiological ac-
tion and pathways involved. Moreover, some antibiotics,
including penicillins, cephalosporins, sulphonamides, as
well as some antiepileptic drugs can cause MC degranu-
lation by acting through IgE receptors on MCs, trigger-
ing degranulation [28].
Changes in the number of MCs have been reported in
wound healing [30], keloid formation [31], chronic in-
flammation [32], parasitic infestation [33], urticaria, atopic
eczema, lichen planus, psoriasis, pretibial myxedema,
scleroderma, neural tumour and mycosis fungoides [17].
The factors involved in the increased number of MCs in
such conditions remain unclear [34]. In addition, percent-
age MC degranulation correlated positively with initial
parasite count (rs = 0.66, p <0.0001), indicating that MCs
are activated in severe P. falciparum malaria. Normally,
MCs can undergo repeated rounds of degranulation and
regranulation [35-38]. An in vitro human lung MC culture
showed late recovery (18–48 hr) from IgE-induced MC
degranulation [39]. In addition, mouse MCs recovered
from degranulation at 30 min after activation [40]. How-
ever, another study reported MCs regenerated from horse-
radish peroxidase induced MC degranulation after six
weeks [41]. At day 7 post-treatment, MC degranulation of
uncomplicated (day 0 = 31.35% ± 3.29, day 7 = 23.93% ±
1.07, p = 0.091) and complicated P. falciparum (day 0 =
43.72% ± 1.44, day 7 = 40.32 ± 1.81%, p = 0.349) remained
elevated. The process of MC regranulation at day 7 was
not observed in the study, indicating that MC regranula-
tion in the skin of P. falciparum is a delayed response
(over seven days).
Parenchymatous changes, including RBC extravasa-
tion, perivascular oedema and leukocytic infiltration
were significantly increased in the malaria groups. It can
be speculated that RBC extravasation and perivascular
oedema are secondary to endothelial cell damage, fol-
lowing cyto-adhesion and sequestration of PRBCs, and
the local effects of MC cytoplasmic granules, such as
TNF, histamine, heparin, and proteases [42]. In addition,
histamine, the major MC mediator in malaria, causes in-
creased vascular permeability and subsequent extensive
vascular damage to endothelial cells [43]. Inflammatory
reactions can also be related to immune responses
during malaria infection.
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MC activation and degranulation are observed in the
skin dermis of severe P. falciparum malaria patients. In
addition, the number of MCs and the degree of degranu-
lation correlate with parasitaemia and disease severity.
Associated histopathological changes in the dermis dur-
ing malaria infection include extravasation of RBCs,
perivascular oedema and leukocyte infiltration around
the blood vessels.
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